Back to Awarded Treatment Trials
Awarded Trial: 14T-011
Grant ID
14T-011
Illness
Bipolar disorder
Primary Drug/Intervention
Cannabidiol
Primary Dosage
200-400 mg
Secondary Drug Intervention
mood stabilizer and/or antipsychotic drug treatment
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Cancelled
Investigator
Rentzsch
Sample Size
82
Duration of Study Period for Each Subject
56 days
Outcome Measurements
Primary efficacy endpoint: Decline in Hamilton Rating Scale for Depression (HDRS) score from baseline to week 8
Results
N/A
Publication
N/A
Link
N/A
PI Name
Johannes Rentzsch
Degree
MD
Center
N/A
Institution
Charite-Universitatsmedizin Berlin
Address
Chariteplatz 1
City or Town
Berlin
State or Province
N/A
Zip or Postal Code
10117
Country
Germany
Email Address
johannes.retzsch@charite.de